nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrahydrobiopterin—NOS3—Doxorubicin—hematologic cancer	0.15	0.302	CbGbCtD
Tetrahydrobiopterin—PTGS2—Lenalidomide—hematologic cancer	0.121	0.244	CbGbCtD
Tetrahydrobiopterin—PTGS2—Thalidomide—hematologic cancer	0.0648	0.13	CbGbCtD
Tetrahydrobiopterin—PTGS2—Triamcinolone—hematologic cancer	0.0449	0.0904	CbGbCtD
Tetrahydrobiopterin—PTGS2—Betamethasone—hematologic cancer	0.0385	0.0775	CbGbCtD
Tetrahydrobiopterin—PTGS2—Cisplatin—hematologic cancer	0.0278	0.0558	CbGbCtD
Tetrahydrobiopterin—PTGS2—Etoposide—hematologic cancer	0.0273	0.0548	CbGbCtD
Tetrahydrobiopterin—PTGS2—Dexamethasone—hematologic cancer	0.0224	0.0451	CbGbCtD
Tetrahydrobiopterin—PTGS2—ovarian follicle—hematologic cancer	0.0102	0.207	CbGeAlD
Tetrahydrobiopterin—TPH1—hematopoietic system—hematologic cancer	0.00904	0.184	CbGeAlD
Tetrahydrobiopterin—PAH—hematopoietic system—hematologic cancer	0.00709	0.145	CbGeAlD
Tetrahydrobiopterin—PAH—blood—hematologic cancer	0.0047	0.0958	CbGeAlD
Tetrahydrobiopterin—NOS3—hematopoietic system—hematologic cancer	0.00387	0.0789	CbGeAlD
Tetrahydrobiopterin—NOS3—blood—hematologic cancer	0.00256	0.0523	CbGeAlD
Tetrahydrobiopterin—NOS3—lung—hematologic cancer	0.00225	0.0458	CbGeAlD
Tetrahydrobiopterin—NOS3—testis—hematologic cancer	0.00212	0.0432	CbGeAlD
Tetrahydrobiopterin—TH—lymph node—hematologic cancer	0.00171	0.0348	CbGeAlD
Tetrahydrobiopterin—NOS3—lymph node—hematologic cancer	0.00154	0.0313	CbGeAlD
Tetrahydrobiopterin—PTGS2—hematopoietic system—hematologic cancer	0.00123	0.025	CbGeAlD
Tetrahydrobiopterin—PTGS2—blood—hematologic cancer	0.000812	0.0166	CbGeAlD
Tetrahydrobiopterin—PTGS2—bone marrow—hematologic cancer	0.000786	0.016	CbGeAlD
Tetrahydrobiopterin—PTGS2—lung—hematologic cancer	0.000712	0.0145	CbGeAlD
Tetrahydrobiopterin—PTGS2—Fluocinonide—Dexamethasone—hematologic cancer	0.000621	0.209	CbGdCrCtD
Tetrahydrobiopterin—PTGS2—Fluocinonide—Betamethasone—hematologic cancer	0.000621	0.209	CbGdCrCtD
Tetrahydrobiopterin—PTGS2—Fluocinonide—Triamcinolone—hematologic cancer	0.000607	0.205	CbGdCrCtD
Tetrahydrobiopterin—PTGS2—lymph node—hematologic cancer	0.000487	0.00993	CbGeAlD
Tetrahydrobiopterin—PTGS2—Fluticasone Propionate—Dexamethasone—hematologic cancer	0.000375	0.126	CbGdCrCtD
Tetrahydrobiopterin—PTGS2—Fluticasone Propionate—Betamethasone—hematologic cancer	0.000375	0.126	CbGdCrCtD
Tetrahydrobiopterin—PTGS2—Fluticasone Propionate—Triamcinolone—hematologic cancer	0.000366	0.124	CbGdCrCtD
Tetrahydrobiopterin—Neutropenia—Epirubicin—hematologic cancer	9.32e-05	0.000367	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Thalidomide—hematologic cancer	9.31e-05	0.000366	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Thiotepa—hematologic cancer	9.31e-05	0.000366	CcSEcCtD
Tetrahydrobiopterin—Rash—Vinorelbine—hematologic cancer	9.29e-05	0.000366	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Vinorelbine—hematologic cancer	9.28e-05	0.000365	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Epirubicin—hematologic cancer	9.26e-05	0.000364	CcSEcCtD
Tetrahydrobiopterin—Headache—Vinorelbine—hematologic cancer	9.23e-05	0.000363	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Vincristine—hematologic cancer	9.19e-05	0.000362	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Triamcinolone—hematologic cancer	9.17e-05	0.000361	CcSEcCtD
Tetrahydrobiopterin—Infection—Triamcinolone—hematologic cancer	9.11e-05	0.000358	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Thalidomide—hematologic cancer	9e-05	0.000354	CcSEcCtD
Tetrahydrobiopterin—Nausea—Bortezomib—hematologic cancer	8.96e-05	0.000353	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Mitoxantrone—hematologic cancer	8.95e-05	0.000352	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Irinotecan—hematologic cancer	8.95e-05	0.000352	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Thiotepa—hematologic cancer	8.95e-05	0.000352	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Carmustine—hematologic cancer	8.94e-05	0.000352	CcSEcCtD
Tetrahydrobiopterin—Nausea—Bleomycin—hematologic cancer	8.89e-05	0.00035	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Epirubicin—hematologic cancer	8.88e-05	0.00035	CcSEcCtD
Tetrahydrobiopterin—Infestation—Epirubicin—hematologic cancer	8.88e-05	0.00035	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Prednisone—hematologic cancer	8.88e-05	0.000349	CcSEcCtD
Tetrahydrobiopterin—Rash—Thiotepa—hematologic cancer	8.87e-05	0.000349	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Thiotepa—hematologic cancer	8.86e-05	0.000349	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Alitretinoin—hematologic cancer	8.86e-05	0.000349	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Dexamethasone—hematologic cancer	8.83e-05	0.000347	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Betamethasone—hematologic cancer	8.83e-05	0.000347	CcSEcCtD
Tetrahydrobiopterin—Headache—Thiotepa—hematologic cancer	8.82e-05	0.000347	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Ifosfamide—hematologic cancer	8.76e-05	0.000345	CcSEcCtD
Tetrahydrobiopterin—Nausea—Vinorelbine—hematologic cancer	8.75e-05	0.000344	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Etoposide—hematologic cancer	8.73e-05	0.000343	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Cisplatin—hematologic cancer	8.72e-05	0.000343	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Thalidomide—hematologic cancer	8.65e-05	0.00034	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Carmustine—hematologic cancer	8.64e-05	0.00034	CcSEcCtD
Tetrahydrobiopterin—Urinary tract infection—Epirubicin—hematologic cancer	8.64e-05	0.00034	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Doxorubicin—hematologic cancer	8.62e-05	0.000339	CcSEcCtD
Tetrahydrobiopterin—Rash—Thalidomide—hematologic cancer	8.58e-05	0.000338	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Thalidomide—hematologic cancer	8.57e-05	0.000337	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Doxorubicin—hematologic cancer	8.57e-05	0.000337	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Alitretinoin—hematologic cancer	8.56e-05	0.000337	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Vincristine—hematologic cancer	8.54e-05	0.000336	CcSEcCtD
Tetrahydrobiopterin—Headache—Thalidomide—hematologic cancer	8.53e-05	0.000335	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Ifosfamide—hematologic cancer	8.46e-05	0.000333	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Methotrexate—hematologic cancer	8.46e-05	0.000333	CcSEcCtD
Tetrahydrobiopterin—Nausea—Thiotepa—hematologic cancer	8.36e-05	0.000329	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	8.35e-05	0.000329	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Dexamethasone—hematologic cancer	8.32e-05	0.000327	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Betamethasone—hematologic cancer	8.32e-05	0.000327	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Irinotecan—hematologic cancer	8.31e-05	0.000327	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Mitoxantrone—hematologic cancer	8.31e-05	0.000327	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Carmustine—hematologic cancer	8.31e-05	0.000327	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Etoposide—hematologic cancer	8.27e-05	0.000325	CcSEcCtD
Tetrahydrobiopterin—Infection—Betamethasone—hematologic cancer	8.26e-05	0.000325	CcSEcCtD
Tetrahydrobiopterin—Infection—Dexamethasone—hematologic cancer	8.26e-05	0.000325	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Vincristine—hematologic cancer	8.25e-05	0.000325	CcSEcCtD
Tetrahydrobiopterin—Rash—Carmustine—hematologic cancer	8.24e-05	0.000324	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Carmustine—hematologic cancer	8.23e-05	0.000324	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Alitretinoin—hematologic cancer	8.23e-05	0.000324	CcSEcCtD
Tetrahydrobiopterin—Infestation—Doxorubicin—hematologic cancer	8.22e-05	0.000323	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Doxorubicin—hematologic cancer	8.22e-05	0.000323	CcSEcCtD
Tetrahydrobiopterin—Headache—Carmustine—hematologic cancer	8.19e-05	0.000322	CcSEcCtD
Tetrahydrobiopterin—Rash—Alitretinoin—hematologic cancer	8.16e-05	0.000321	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Dexamethasone—hematologic cancer	8.16e-05	0.000321	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Betamethasone—hematologic cancer	8.16e-05	0.000321	CcSEcCtD
Tetrahydrobiopterin—Agitation—Prednisone—hematologic cancer	8.16e-05	0.000321	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Alitretinoin—hematologic cancer	8.16e-05	0.000321	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Ifosfamide—hematologic cancer	8.14e-05	0.00032	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Cisplatin—hematologic cancer	8.13e-05	0.00032	CcSEcCtD
Tetrahydrobiopterin—Headache—Alitretinoin—hematologic cancer	8.11e-05	0.000319	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Gemcitabine—hematologic cancer	8.1e-05	0.000319	CcSEcCtD
Tetrahydrobiopterin—Nausea—Thalidomide—hematologic cancer	8.08e-05	0.000318	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Triamcinolone—hematologic cancer	8.07e-05	0.000318	CcSEcCtD
Tetrahydrobiopterin—Rash—Ifosfamide—hematologic cancer	8.07e-05	0.000318	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Ifosfamide—hematologic cancer	8.06e-05	0.000317	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Irinotecan—hematologic cancer	8.04e-05	0.000316	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Etoposide—hematologic cancer	7.99e-05	0.000314	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Etoposide—hematologic cancer	7.99e-05	0.000314	CcSEcCtD
Tetrahydrobiopterin—Urinary tract infection—Doxorubicin—hematologic cancer	7.99e-05	0.000314	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Vincristine—hematologic cancer	7.93e-05	0.000312	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Epirubicin—hematologic cancer	7.92e-05	0.000311	CcSEcCtD
Tetrahydrobiopterin—Rash—Vincristine—hematologic cancer	7.87e-05	0.00031	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Vincristine—hematologic cancer	7.86e-05	0.000309	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Epirubicin—hematologic cancer	7.86e-05	0.000309	CcSEcCtD
Tetrahydrobiopterin—Headache—Vincristine—hematologic cancer	7.82e-05	0.000308	CcSEcCtD
Tetrahydrobiopterin—Nausea—Carmustine—hematologic cancer	7.76e-05	0.000305	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Mitoxantrone—hematologic cancer	7.73e-05	0.000304	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Irinotecan—hematologic cancer	7.73e-05	0.000304	CcSEcCtD
Tetrahydrobiopterin—Nausea—Alitretinoin—hematologic cancer	7.69e-05	0.000303	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Prednisone—hematologic cancer	7.69e-05	0.000303	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Methotrexate—hematologic cancer	7.68e-05	0.000302	CcSEcCtD
Tetrahydrobiopterin—Rash—Mitoxantrone—hematologic cancer	7.66e-05	0.000301	CcSEcCtD
Tetrahydrobiopterin—Rash—Irinotecan—hematologic cancer	7.66e-05	0.000301	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Irinotecan—hematologic cancer	7.65e-05	0.000301	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Mitoxantrone—hematologic cancer	7.65e-05	0.000301	CcSEcCtD
Tetrahydrobiopterin—Headache—Mitoxantrone—hematologic cancer	7.61e-05	0.0003	CcSEcCtD
Tetrahydrobiopterin—Headache—Irinotecan—hematologic cancer	7.61e-05	0.0003	CcSEcCtD
Tetrahydrobiopterin—Nausea—Ifosfamide—hematologic cancer	7.6e-05	0.000299	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	7.58e-05	0.000298	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Betamethasone—hematologic cancer	7.58e-05	0.000298	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Prednisone—hematologic cancer	7.56e-05	0.000297	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Cisplatin—hematologic cancer	7.55e-05	0.000297	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Gemcitabine—hematologic cancer	7.53e-05	0.000296	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	7.5e-05	0.000295	CcSEcCtD
Tetrahydrobiopterin—Rash—Gemcitabine—hematologic cancer	7.46e-05	0.000294	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Gemcitabine—hematologic cancer	7.46e-05	0.000293	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Etoposide—hematologic cancer	7.45e-05	0.000293	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Methotrexate—hematologic cancer	7.42e-05	0.000292	CcSEcCtD
Tetrahydrobiopterin—Headache—Gemcitabine—hematologic cancer	7.42e-05	0.000292	CcSEcCtD
Tetrahydrobiopterin—Nausea—Vincristine—hematologic cancer	7.41e-05	0.000292	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Prednisolone—hematologic cancer	7.34e-05	0.000289	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Doxorubicin—hematologic cancer	7.32e-05	0.000288	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Dexamethasone—hematologic cancer	7.32e-05	0.000288	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Betamethasone—hematologic cancer	7.32e-05	0.000288	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Doxorubicin—hematologic cancer	7.27e-05	0.000286	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Triamcinolone—hematologic cancer	7.25e-05	0.000285	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Prednisone—hematologic cancer	7.24e-05	0.000285	CcSEcCtD
Tetrahydrobiopterin—Nausea—Mitoxantrone—hematologic cancer	7.22e-05	0.000284	CcSEcCtD
Tetrahydrobiopterin—Nausea—Irinotecan—hematologic cancer	7.22e-05	0.000284	CcSEcCtD
Tetrahydrobiopterin—Infection—Prednisone—hematologic cancer	7.2e-05	0.000283	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Epirubicin—hematologic cancer	7.19e-05	0.000283	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Dexamethasone—hematologic cancer	7.18e-05	0.000283	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Betamethasone—hematologic cancer	7.18e-05	0.000283	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Prednisone—hematologic cancer	7.1e-05	0.00028	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Prednisone—hematologic cancer	7.04e-05	0.000277	CcSEcCtD
Tetrahydrobiopterin—Nausea—Gemcitabine—hematologic cancer	7.03e-05	0.000277	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Cisplatin—hematologic cancer	7.01e-05	0.000276	CcSEcCtD
Tetrahydrobiopterin—Rash—Cisplatin—hematologic cancer	6.96e-05	0.000274	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Cisplatin—hematologic cancer	6.95e-05	0.000273	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Epirubicin—hematologic cancer	6.94e-05	0.000273	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Etoposide—hematologic cancer	6.92e-05	0.000272	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Dexamethasone—hematologic cancer	6.8e-05	0.000268	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Betamethasone—hematologic cancer	6.8e-05	0.000268	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Triamcinolone—hematologic cancer	6.75e-05	0.000266	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Etoposide—hematologic cancer	6.68e-05	0.000263	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Doxorubicin—hematologic cancer	6.65e-05	0.000262	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Prednisone—hematologic cancer	6.6e-05	0.00026	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Prednisolone—hematologic cancer	6.59e-05	0.000259	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Betamethasone—hematologic cancer	6.58e-05	0.000259	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Dexamethasone—hematologic cancer	6.58e-05	0.000259	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Dexamethasone—hematologic cancer	6.58e-05	0.000259	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Betamethasone—hematologic cancer	6.58e-05	0.000259	CcSEcCtD
Tetrahydrobiopterin—Nausea—Cisplatin—hematologic cancer	6.55e-05	0.000258	CcSEcCtD
Tetrahydrobiopterin—Cough—Methotrexate—hematologic cancer	6.47e-05	0.000255	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Methotrexate—hematologic cancer	6.43e-05	0.000253	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Etoposide—hematologic cancer	6.43e-05	0.000253	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Doxorubicin—hematologic cancer	6.42e-05	0.000253	CcSEcCtD
Tetrahydrobiopterin—Agitation—Epirubicin—hematologic cancer	6.38e-05	0.000251	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Prednisone—hematologic cancer	6.38e-05	0.000251	CcSEcCtD
Tetrahydrobiopterin—Rash—Etoposide—hematologic cancer	6.37e-05	0.000251	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Etoposide—hematologic cancer	6.37e-05	0.000251	CcSEcCtD
Tetrahydrobiopterin—Headache—Etoposide—hematologic cancer	6.33e-05	0.000249	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Methotrexate—hematologic cancer	6.32e-05	0.000249	CcSEcCtD
Tetrahydrobiopterin—Rash—Prednisolone—hematologic cancer	6.29e-05	0.000247	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Prednisolone—hematologic cancer	6.28e-05	0.000247	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	6.27e-05	0.000247	CcSEcCtD
Tetrahydrobiopterin—Headache—Prednisolone—hematologic cancer	6.25e-05	0.000246	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Triamcinolone—hematologic cancer	6.06e-05	0.000239	CcSEcCtD
Tetrahydrobiopterin—Cough—Epirubicin—hematologic cancer	6.06e-05	0.000238	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Methotrexate—hematologic cancer	6.05e-05	0.000238	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Epirubicin—hematologic cancer	6.01e-05	0.000237	CcSEcCtD
Tetrahydrobiopterin—Infection—Methotrexate—hematologic cancer	6.01e-05	0.000237	CcSEcCtD
Tetrahydrobiopterin—Nausea—Etoposide—hematologic cancer	6e-05	0.000236	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Methotrexate—hematologic cancer	5.94e-05	0.000234	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Prednisone—hematologic cancer	5.92e-05	0.000233	CcSEcCtD
Tetrahydrobiopterin—Nausea—Prednisolone—hematologic cancer	5.92e-05	0.000233	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Epirubicin—hematologic cancer	5.91e-05	0.000233	CcSEcCtD
Tetrahydrobiopterin—Agitation—Doxorubicin—hematologic cancer	5.9e-05	0.000232	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Methotrexate—hematologic cancer	5.88e-05	0.000231	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	5.87e-05	0.000231	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Triamcinolone—hematologic cancer	5.83e-05	0.000229	CcSEcCtD
Tetrahydrobiopterin—Rash—Triamcinolone—hematologic cancer	5.78e-05	0.000227	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Triamcinolone—hematologic cancer	5.78e-05	0.000227	CcSEcCtD
Tetrahydrobiopterin—Headache—Triamcinolone—hematologic cancer	5.74e-05	0.000226	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Prednisone—hematologic cancer	5.73e-05	0.000225	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Prednisone—hematologic cancer	5.73e-05	0.000225	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Betamethasone—hematologic cancer	5.69e-05	0.000224	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Dexamethasone—hematologic cancer	5.69e-05	0.000224	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Epirubicin—hematologic cancer	5.67e-05	0.000223	CcSEcCtD
Tetrahydrobiopterin—Infection—Epirubicin—hematologic cancer	5.63e-05	0.000221	CcSEcCtD
Tetrahydrobiopterin—Cough—Doxorubicin—hematologic cancer	5.61e-05	0.000221	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Doxorubicin—hematologic cancer	5.57e-05	0.000219	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Epirubicin—hematologic cancer	5.56e-05	0.000219	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Methotrexate—hematologic cancer	5.52e-05	0.000217	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Epirubicin—hematologic cancer	5.5e-05	0.000217	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Dexamethasone—hematologic cancer	5.5e-05	0.000216	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Betamethasone—hematologic cancer	5.5e-05	0.000216	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Doxorubicin—hematologic cancer	5.47e-05	0.000215	CcSEcCtD
Tetrahydrobiopterin—Nausea—Triamcinolone—hematologic cancer	5.45e-05	0.000214	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	5.43e-05	0.000214	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Prednisone—hematologic cancer	5.34e-05	0.00021	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Methotrexate—hematologic cancer	5.33e-05	0.00021	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Betamethasone—hematologic cancer	5.29e-05	0.000208	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Dexamethasone—hematologic cancer	5.29e-05	0.000208	CcSEcCtD
Tetrahydrobiopterin—Rash—Dexamethasone—hematologic cancer	5.24e-05	0.000206	CcSEcCtD
Tetrahydrobiopterin—Rash—Betamethasone—hematologic cancer	5.24e-05	0.000206	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Doxorubicin—hematologic cancer	5.24e-05	0.000206	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Betamethasone—hematologic cancer	5.24e-05	0.000206	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Dexamethasone—hematologic cancer	5.24e-05	0.000206	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Methotrexate—hematologic cancer	5.23e-05	0.000206	CcSEcCtD
Tetrahydrobiopterin—Headache—Betamethasone—hematologic cancer	5.21e-05	0.000205	CcSEcCtD
Tetrahydrobiopterin—Headache—Dexamethasone—hematologic cancer	5.21e-05	0.000205	CcSEcCtD
Tetrahydrobiopterin—Infection—Doxorubicin—hematologic cancer	5.21e-05	0.000205	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Epirubicin—hematologic cancer	5.16e-05	0.000203	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Doxorubicin—hematologic cancer	5.14e-05	0.000202	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Doxorubicin—hematologic cancer	5.09e-05	0.0002	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Epirubicin—hematologic cancer	4.99e-05	0.000196	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Prednisone—hematologic cancer	4.96e-05	0.000195	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Methotrexate—hematologic cancer	4.95e-05	0.000195	CcSEcCtD
Tetrahydrobiopterin—Nausea—Dexamethasone—hematologic cancer	4.94e-05	0.000194	CcSEcCtD
Tetrahydrobiopterin—Nausea—Betamethasone—hematologic cancer	4.94e-05	0.000194	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Epirubicin—hematologic cancer	4.89e-05	0.000192	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Prednisone—hematologic cancer	4.79e-05	0.000188	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Methotrexate—hematologic cancer	4.79e-05	0.000188	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Methotrexate—hematologic cancer	4.79e-05	0.000188	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	4.78e-05	0.000188	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Epirubicin—hematologic cancer	4.63e-05	0.000182	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Doxorubicin—hematologic cancer	4.61e-05	0.000182	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Prednisone—hematologic cancer	4.61e-05	0.000181	CcSEcCtD
Tetrahydrobiopterin—Rash—Prednisone—hematologic cancer	4.57e-05	0.00018	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Prednisone—hematologic cancer	4.56e-05	0.00018	CcSEcCtD
Tetrahydrobiopterin—Headache—Prednisone—hematologic cancer	4.54e-05	0.000179	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Doxorubicin—hematologic cancer	4.53e-05	0.000178	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Epirubicin—hematologic cancer	4.48e-05	0.000176	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Epirubicin—hematologic cancer	4.48e-05	0.000176	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Methotrexate—hematologic cancer	4.46e-05	0.000176	CcSEcCtD
Tetrahydrobiopterin—Nausea—Prednisone—hematologic cancer	4.3e-05	0.000169	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Doxorubicin—hematologic cancer	4.29e-05	0.000169	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Epirubicin—hematologic cancer	4.17e-05	0.000164	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Doxorubicin—hematologic cancer	4.14e-05	0.000163	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Doxorubicin—hematologic cancer	4.14e-05	0.000163	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Methotrexate—hematologic cancer	4.14e-05	0.000163	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Methotrexate—hematologic cancer	4e-05	0.000158	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Epirubicin—hematologic cancer	3.88e-05	0.000153	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Doxorubicin—hematologic cancer	3.86e-05	0.000152	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Methotrexate—hematologic cancer	3.85e-05	0.000151	CcSEcCtD
Tetrahydrobiopterin—Rash—Methotrexate—hematologic cancer	3.82e-05	0.00015	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Methotrexate—hematologic cancer	3.81e-05	0.00015	CcSEcCtD
Tetrahydrobiopterin—Headache—Methotrexate—hematologic cancer	3.79e-05	0.000149	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Epirubicin—hematologic cancer	3.75e-05	0.000147	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Epirubicin—hematologic cancer	3.6e-05	0.000142	CcSEcCtD
Tetrahydrobiopterin—Nausea—Methotrexate—hematologic cancer	3.6e-05	0.000142	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Doxorubicin—hematologic cancer	3.59e-05	0.000141	CcSEcCtD
Tetrahydrobiopterin—Rash—Epirubicin—hematologic cancer	3.57e-05	0.000141	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Epirubicin—hematologic cancer	3.57e-05	0.00014	CcSEcCtD
Tetrahydrobiopterin—Headache—Epirubicin—hematologic cancer	3.55e-05	0.00014	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Doxorubicin—hematologic cancer	3.47e-05	0.000136	CcSEcCtD
Tetrahydrobiopterin—Nausea—Epirubicin—hematologic cancer	3.37e-05	0.000132	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Doxorubicin—hematologic cancer	3.33e-05	0.000131	CcSEcCtD
Tetrahydrobiopterin—Rash—Doxorubicin—hematologic cancer	3.31e-05	0.00013	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Doxorubicin—hematologic cancer	3.3e-05	0.00013	CcSEcCtD
Tetrahydrobiopterin—Headache—Doxorubicin—hematologic cancer	3.28e-05	0.000129	CcSEcCtD
Tetrahydrobiopterin—Nausea—Doxorubicin—hematologic cancer	3.11e-05	0.000123	CcSEcCtD
Tetrahydrobiopterin—NOS3—Metabolism—MTHFR—hematologic cancer	1.35e-05	6.86e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CDKN2B—hematologic cancer	1.35e-05	6.84e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—NCOR2—hematologic cancer	1.34e-05	6.82e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—FGF19—hematologic cancer	1.33e-05	6.79e-05	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—PIK3CA—hematologic cancer	1.33e-05	6.76e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PTPN11—hematologic cancer	1.33e-05	6.76e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—RPS14—hematologic cancer	1.32e-05	6.73e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—EP300—hematologic cancer	1.31e-05	6.69e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—DKK1—hematologic cancer	1.31e-05	6.68e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—PIK3CA—hematologic cancer	1.31e-05	6.64e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—STAT5B—hematologic cancer	1.3e-05	6.63e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—NUP98—hematologic cancer	1.3e-05	6.63e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CD86—hematologic cancer	1.3e-05	6.62e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CREB1—hematologic cancer	1.29e-05	6.55e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—HES1—hematologic cancer	1.28e-05	6.53e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—IDH1—hematologic cancer	1.28e-05	6.5e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	1.28e-05	6.5e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—NCOR1—hematologic cancer	1.28e-05	6.49e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CST3—hematologic cancer	1.27e-05	6.48e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—BRAF—hematologic cancer	1.27e-05	6.47e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	1.27e-05	6.45e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—ADCY7—hematologic cancer	1.27e-05	6.43e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ABCC3—hematologic cancer	1.26e-05	6.43e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—TXN—hematologic cancer	1.26e-05	6.43e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GSTO1—hematologic cancer	1.26e-05	6.43e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—KRAS—hematologic cancer	1.26e-05	6.43e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—TP53—hematologic cancer	1.26e-05	6.42e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CSF2—hematologic cancer	1.26e-05	6.42e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—FGF1—hematologic cancer	1.26e-05	6.42e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—IL6R—hematologic cancer	1.26e-05	6.39e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—NUP214—hematologic cancer	1.26e-05	6.39e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CREBBP—hematologic cancer	1.26e-05	6.38e-05	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PIK3CB—hematologic cancer	1.25e-05	6.37e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—FOXO1—hematologic cancer	1.24e-05	6.33e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PDGFRB—hematologic cancer	1.24e-05	6.31e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—SPHK1—hematologic cancer	1.24e-05	6.29e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MTR—hematologic cancer	1.23e-05	6.26e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—XIAP—hematologic cancer	1.23e-05	6.26e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PDGFRA—hematologic cancer	1.22e-05	6.22e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PRKCG—hematologic cancer	1.22e-05	6.2e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—JAK1—hematologic cancer	1.22e-05	6.2e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—HRAS—hematologic cancer	1.21e-05	6.14e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—ENO2—hematologic cancer	1.21e-05	6.14e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—SMARCA4—hematologic cancer	1.2e-05	6.1e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—MAP2K1—hematologic cancer	1.2e-05	6.09e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PIK3CD—hematologic cancer	1.19e-05	6.05e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—UGT1A1—hematologic cancer	1.19e-05	6.04e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	1.16e-05	5.92e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—PIK3CA—hematologic cancer	1.16e-05	5.91e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CRABP1—hematologic cancer	1.16e-05	5.88e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—SLC22A1—hematologic cancer	1.16e-05	5.88e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—SDC1—hematologic cancer	1.14e-05	5.82e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—FGF2—hematologic cancer	1.14e-05	5.79e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IL2RA—hematologic cancer	1.14e-05	5.79e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PIK3CG—hematologic cancer	1.13e-05	5.76e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ALOX5—hematologic cancer	1.13e-05	5.73e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	1.13e-05	5.73e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TERT—hematologic cancer	1.13e-05	5.72e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PIK3R1—hematologic cancer	1.12e-05	5.71e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—LCK—hematologic cancer	1.11e-05	5.63e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PDGFB—hematologic cancer	1.1e-05	5.58e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—JAK2—hematologic cancer	1.09e-05	5.55e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—NUP98—hematologic cancer	1.09e-05	5.55e-05	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—AKT1—hematologic cancer	1.09e-05	5.53e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—H3F3A—hematologic cancer	1.09e-05	5.52e-05	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PTEN—hematologic cancer	1.08e-05	5.51e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—HRAS—hematologic cancer	1.07e-05	5.46e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TSC2—hematologic cancer	1.07e-05	5.46e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—AKT1—hematologic cancer	1.07e-05	5.43e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—MDM2—hematologic cancer	1.07e-05	5.42e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ADCY7—hematologic cancer	1.06e-05	5.39e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—NCOA3—hematologic cancer	1.06e-05	5.39e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PRKCZ—hematologic cancer	1.06e-05	5.37e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—NUP214—hematologic cancer	1.05e-05	5.35e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—CREBBP—hematologic cancer	1.05e-05	5.34e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.04e-05	5.29e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—MTOR—hematologic cancer	1.04e-05	5.27e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PIK3CB—hematologic cancer	1.04e-05	5.27e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CALR—hematologic cancer	1.04e-05	5.27e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CD4—hematologic cancer	1.04e-05	5.26e-05	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—EP300—hematologic cancer	1.03e-05	5.25e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—FGFR3—hematologic cancer	1.03e-05	5.25e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—MTR—hematologic cancer	1.03e-05	5.24e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ABCG2—hematologic cancer	1.03e-05	5.24e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—IL6—hematologic cancer	1.03e-05	5.23e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MAPK14—hematologic cancer	1.02e-05	5.2e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PARP1—hematologic cancer	1.02e-05	5.18e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ENO2—hematologic cancer	1.01e-05	5.14e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—FBXW7—hematologic cancer	1e-05	5.1e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—ESR1—hematologic cancer	1e-05	5.1e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PIK3CD—hematologic cancer	9.97e-06	5.07e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—FN1—hematologic cancer	9.91e-06	5.04e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—ALB—hematologic cancer	9.84e-06	5e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—HDAC2—hematologic cancer	9.84e-06	5e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CXCR4—hematologic cancer	9.84e-06	5e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GSTT1—hematologic cancer	9.8e-06	4.98e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—BAD—hematologic cancer	9.79e-06	4.98e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—NFKBIA—hematologic cancer	9.79e-06	4.98e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CDKN1B—hematologic cancer	9.74e-06	4.95e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CD44—hematologic cancer	9.73e-06	4.95e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—PIK3CA—hematologic cancer	9.73e-06	4.95e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—NOTCH1—hematologic cancer	9.7e-06	4.93e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	9.65e-06	4.91e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CBL—hematologic cancer	9.59e-06	4.87e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—SDC1—hematologic cancer	9.58e-06	4.87e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	9.51e-06	4.84e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CD80—hematologic cancer	9.5e-06	4.83e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—AKT1—hematologic cancer	9.49e-06	4.82e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PIK3CG—hematologic cancer	9.48e-06	4.82e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—KIT—hematologic cancer	9.48e-06	4.82e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PIK3R1—hematologic cancer	9.41e-06	4.79e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PTPN11—hematologic cancer	9.31e-06	4.74e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	9.15e-06	4.65e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—HSP90AA1—hematologic cancer	9.15e-06	4.65e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	9.04e-06	4.59e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CREB1—hematologic cancer	9.02e-06	4.59e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CDKN1A—hematologic cancer	8.98e-06	4.57e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PTEN—hematologic cancer	8.96e-06	4.56e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—BRAF—hematologic cancer	8.91e-06	4.53e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CCL2—hematologic cancer	8.83e-06	4.49e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—STAT1—hematologic cancer	8.82e-06	4.48e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IL6R—hematologic cancer	8.8e-06	4.48e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CREBBP—hematologic cancer	8.79e-06	4.47e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PIK3CB—hematologic cancer	8.69e-06	4.42e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	8.64e-06	4.39e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—EP300—hematologic cancer	8.55e-06	4.35e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MAP2K1—hematologic cancer	8.39e-06	4.27e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PIK3CD—hematologic cancer	8.33e-06	4.24e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—SRC—hematologic cancer	8.31e-06	4.23e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—GRB2—hematologic cancer	8.25e-06	4.2e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PDGFA—hematologic cancer	8.23e-06	4.19e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CD44—hematologic cancer	8.15e-06	4.14e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—NQO1—hematologic cancer	8.15e-06	4.14e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—KITLG—hematologic cancer	8.11e-06	4.13e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—STAT3—hematologic cancer	8.02e-06	4.08e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—NRAS—hematologic cancer	8e-06	4.07e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—FGF2—hematologic cancer	7.98e-06	4.06e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	7.98e-06	4.06e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—AKT1—hematologic cancer	7.95e-06	4.04e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—STAT5A—hematologic cancer	7.93e-06	4.03e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PIK3R1—hematologic cancer	7.87e-06	4e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CDKN2B—hematologic cancer	7.86e-06	4e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CYCS—hematologic cancer	7.71e-06	3.92e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—HSP90AA1—hematologic cancer	7.66e-06	3.89e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—MAPK3—hematologic cancer	7.66e-06	3.89e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—JAK2—hematologic cancer	7.65e-06	3.89e-05	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PIK3CA—hematologic cancer	7.64e-06	3.88e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CD86—hematologic cancer	7.6e-06	3.87e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PTEN—hematologic cancer	7.51e-06	3.82e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—HES1—hematologic cancer	7.5e-06	3.81e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MDM2—hematologic cancer	7.47e-06	3.8e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—NCOR1—hematologic cancer	7.46e-06	3.79e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—MYC—hematologic cancer	7.45e-06	3.79e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—TGFB1—hematologic cancer	7.43e-06	3.78e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—FGF1—hematologic cancer	7.37e-06	3.75e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—FOXO1—hematologic cancer	7.27e-06	3.69e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MTOR—hematologic cancer	7.26e-06	3.69e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PIK3CB—hematologic cancer	7.26e-06	3.69e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PDGFRB—hematologic cancer	7.25e-06	3.69e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—EP300—hematologic cancer	7.16e-06	3.64e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PDGFRA—hematologic cancer	7.14e-06	3.63e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—JAK1—hematologic cancer	7.12e-06	3.62e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PRKCG—hematologic cancer	7.12e-06	3.62e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	6.89e-06	3.51e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—KRAS—hematologic cancer	6.88e-06	3.5e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CDKN1B—hematologic cancer	6.82e-06	3.47e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GSTP1—hematologic cancer	6.8e-06	3.45e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CASP3—hematologic cancer	6.68e-06	3.4e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IL2—hematologic cancer	6.67e-06	3.39e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MTHFR—hematologic cancer	6.59e-06	3.35e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	6.57e-06	3.34e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—HLA-A—hematologic cancer	6.57e-06	3.34e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—TERT—hematologic cancer	6.57e-06	3.34e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CCND1—hematologic cancer	6.5e-06	3.31e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—JUN—hematologic cancer	6.49e-06	3.3e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ABCB1—hematologic cancer	6.43e-06	3.27e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PDGFB—hematologic cancer	6.41e-06	3.26e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PIK3CA—hematologic cancer	6.32e-06	3.22e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CDKN1A—hematologic cancer	6.29e-06	3.2e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PTEN—hematologic cancer	6.28e-06	3.19e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—TSC2—hematologic cancer	6.27e-06	3.19e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—NCOR1—hematologic cancer	6.24e-06	3.17e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GSTM1—hematologic cancer	6.24e-06	3.17e-05	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—AKT1—hematologic cancer	6.24e-06	3.17e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MAPK8—hematologic cancer	6.14e-06	3.12e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—FGFR3—hematologic cancer	6.03e-06	3.07e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—EP300—hematologic cancer	5.99e-06	3.04e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—HRAS—hematologic cancer	5.85e-06	2.97e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—SRC—hematologic cancer	5.82e-06	2.96e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—BAD—hematologic cancer	5.72e-06	2.91e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—VEGFA—hematologic cancer	5.67e-06	2.88e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—NOTCH1—hematologic cancer	5.66e-06	2.88e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—STAT3—hematologic cancer	5.61e-06	2.85e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—NRAS—hematologic cancer	5.6e-06	2.85e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—IL6—hematologic cancer	5.6e-06	2.85e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CD80—hematologic cancer	5.55e-06	2.82e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—KIT—hematologic cancer	5.54e-06	2.81e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—MTHFR—hematologic cancer	5.52e-06	2.81e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PTPN11—hematologic cancer	5.44e-06	2.77e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MAPK3—hematologic cancer	5.36e-06	2.73e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PIK3CA—hematologic cancer	5.3e-06	2.69e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CREB1—hematologic cancer	5.27e-06	2.68e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MYC—hematologic cancer	5.22e-06	2.65e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—BRAF—hematologic cancer	5.2e-06	2.65e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TGFB1—hematologic cancer	5.2e-06	2.65e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—AKT1—hematologic cancer	5.17e-06	2.63e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—IL6R—hematologic cancer	5.14e-06	2.61e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CREBBP—hematologic cancer	5.13e-06	2.61e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MAP2K1—hematologic cancer	4.9e-06	2.49e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PIK3CD—hematologic cancer	4.87e-06	2.47e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.86e-06	2.47e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—KRAS—hematologic cancer	4.82e-06	2.45e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—FGF2—hematologic cancer	4.66e-06	2.37e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PIK3CG—hematologic cancer	4.64e-06	2.36e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PIK3R1—hematologic cancer	4.6e-06	2.34e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—JAK2—hematologic cancer	4.47e-06	2.27e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PIK3CA—hematologic cancer	4.43e-06	2.25e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MDM2—hematologic cancer	4.36e-06	2.22e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—AKT1—hematologic cancer	4.33e-06	2.2e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CREBBP—hematologic cancer	4.3e-06	2.19e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TP53—hematologic cancer	4.28e-06	2.18e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MTOR—hematologic cancer	4.24e-06	2.16e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PIK3CB—hematologic cancer	4.24e-06	2.16e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CD4—hematologic cancer	4.23e-06	2.15e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—HRAS—hematologic cancer	4.1e-06	2.08e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PIK3CD—hematologic cancer	4.08e-06	2.07e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ALB—hematologic cancer	4.02e-06	2.05e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CDKN1B—hematologic cancer	3.98e-06	2.02e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IL6—hematologic cancer	3.92e-06	1.99e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PIK3R1—hematologic cancer	3.85e-06	1.96e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CDKN1A—hematologic cancer	3.67e-06	1.87e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PTEN—hematologic cancer	3.67e-06	1.86e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—AKT1—hematologic cancer	3.62e-06	1.84e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PIK3CB—hematologic cancer	3.55e-06	1.81e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—EP300—hematologic cancer	3.5e-06	1.78e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—SRC—hematologic cancer	3.4e-06	1.73e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—STAT3—hematologic cancer	3.28e-06	1.67e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—NRAS—hematologic cancer	3.27e-06	1.66e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MAPK3—hematologic cancer	3.13e-06	1.59e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PTEN—hematologic cancer	3.07e-06	1.56e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MYC—hematologic cancer	3.05e-06	1.55e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—TGFB1—hematologic cancer	3.04e-06	1.55e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—EP300—hematologic cancer	2.93e-06	1.49e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—KRAS—hematologic cancer	2.82e-06	1.43e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PIK3CA—hematologic cancer	2.59e-06	1.31e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—HRAS—hematologic cancer	2.39e-06	1.22e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—IL6—hematologic cancer	2.29e-06	1.16e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PIK3CA—hematologic cancer	2.17e-06	1.1e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—AKT1—hematologic cancer	2.11e-06	1.07e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—AKT1—hematologic cancer	1.77e-06	9e-06	CbGpPWpGaD
